Infuvite Adult — Competitive Intelligence Brief

Infuvite Adult (ASCORBIC ACID) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Vitamin C [EPC]. Area: Infectious Disease.

marketed Vitamin C [EPC] Tyrosinase Infectious Disease Small molecule

Target snapshot

Infuvite Adult (ASCORBIC ACID).

Comparator set (6 drugs)

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Infuvite Adult TARGET	ASCORBIC ACID		marketed	Vitamin C [EPC]	Tyrosinase	1985-01-01
Hydroquinone Methyl Ether	MEQUINOL		marketed	Skin Lightening Agent	Tyrosinase	1999-01-01
Shade Uvaguard	AVOBENZONE	Bayer	marketed	avobenzone	Tyrosinase	1992-01-01
Tri-luma	Tri-luma	Hexsel Dermatology Clinic	marketed	Topical depigmenting agent combination	Tyrosinase; retinoic acid receptor; glucocorticoid receptor
LTC 15 minutes	LTC 15 minutes	Netherlands Institute for Pigment Disorders	marketed	Skin lightening agent	Tyrosinase
Arbutyne	ARBUTIN		marketed	Adenosine Receptor Agonist [EPC]	Tyrosinase, Polyphenol oxidase 2, Tyrosinase
Bleaching Agents	Bleaching Agents	André Luis Faria e Silva	marketed	Topical depigmenting agent	Tyrosinase (primary); melanin (direct oxidation)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Vitamin C [EPC] class)

1. · 16 drugs in this class
2. Pfizer · 5 drugs in this class
3. Energique, Inc. · 2 drugs in this class
4. Exela Pharma · 1 drug in this class
5. Faculdade de Medicina do ABC · 1 drug in this class
6. Glaukos · 1 drug in this class
7. Hippocration General Hospital · 1 drug in this class
8. Jun Gong, MD · 1 drug in this class
9. MEDPOINTE PHARM HLC · 1 drug in this class
10. Novartis · 1 drug in this class